ESMO-European Society for Medical Oncology recently shared a post on LinkedIn:
“Studies presented at MAP2024 have shown that sequencing techniques have a wider range of applications in Cancer treatment.
Whole-genome sequencing and single-cell sequencing can offer valuable insights, not only for identifying new therapy targets but also for assessing minimal residual disease and overcoming treatment resistance.”
More posts featuring MAP2024.